These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 7187501)

  • 1. [The immunizing efficacy of anti-influenza vaccines].
    Profeta ML
    Nuovi Ann Ig Microbiol; 1982; 33(4-6):785-97. PubMed ID: 7187501
    [No Abstract]   [Full Text] [Related]  

  • 2. [Role of antineuraminidase antibodies in the human immunological response to the administration of live type A influenza vaccines].
    Naĭkhin AN; Topuriia NV; Denisov GM
    Mikrobiol Zh (1978); 1980; 42(5):642-5. PubMed ID: 7432210
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-neuraminidase antibody response after administration of a split influenza vaccine.
    Constantinescu C; Ioniţă E; Alexandrescu V; Maţepiuc M; Creţescu L; Niculescu IT
    Arch Roum Pathol Exp Microbiol; 1985; 44(1):37-41. PubMed ID: 4038049
    [No Abstract]   [Full Text] [Related]  

  • 4. Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine.
    Belshe R; Lee MS; Walker RE; Stoddard J; Mendelman PM
    Expert Rev Vaccines; 2004 Dec; 3(6):643-54. PubMed ID: 15606348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A field experiment with neuraminidase influenza vaccine (author's transl)].
    Janout V; Uvízl M; Kotíková J; Jukl V
    Cesk Epidemiol Mikrobiol Imunol; 1981 Jul; 30(4):203-12. PubMed ID: 6455206
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of preinfection and preimmunization on the serum antibody response to subsequent immunization with heterotypic influenza vaccines.
    Jennings R; Potter CW; McLaren C
    J Immunol; 1974 Dec; 113(6):1834-43. PubMed ID: 4547776
    [No Abstract]   [Full Text] [Related]  

  • 7. Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine.
    Belshe RB; Gruber WC; Mendelman PM; Mehta HB; Mahmood K; Reisinger K; Treanor J; Zangwill K; Hayden FG; Bernstein DI; Kotloff K; King J; Piedra PA; Block SL; Yan L; Wolff M
    J Infect Dis; 2000 Mar; 181(3):1133-7. PubMed ID: 10720541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-reactive H1N1 antibody responses to a live attenuated influenza vaccine in children: implication for selection of vaccine strains.
    Lee MS; Yang CF
    J Infect Dis; 2003 Nov; 188(9):1362-6. PubMed ID: 14593595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promises and challenges of live-attenuated intranasal influenza vaccines across the age spectrum: a review.
    Boyce TG; Poland GA
    Biomed Pharmacother; 2000 May; 54(4):210-8. PubMed ID: 10872719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuraminidase- and hemagglutinin-inhibiting antibodies in serum and nasal secretions of volunteers immunized with attenuated and inactivated influenza B-Eng-13-65 virus vaccines.
    Downie JC
    J Immunol; 1970 Sep; 105(3):620-6. PubMed ID: 5311581
    [No Abstract]   [Full Text] [Related]  

  • 11. Neuraminidase antibody response to inactivated influenza virus vaccine following intranasal and intramuscular vaccination.
    Muhamed G; Greenbaum E; Zakay-Rones Z
    Isr Med Assoc J; 2006 Mar; 8(3):155-8. PubMed ID: 16599048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sialivac: an intranasal homologous inactivated split virus vaccine containing bacterial sialidase for the control of avian influenza in poultry.
    Worrall EE; Sudarisman ; Priadi A
    Vaccine; 2009 Jun; 27(31):4161-8. PubMed ID: 19406183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nasal influenza vaccine enters Phase I clinical trial.
    Expert Rev Vaccines; 2007 Jun; 6(3):305. PubMed ID: 17542745
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunization against influenza A virus: comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system.
    Brett IC; Johansson BE
    Virology; 2005 Sep; 339(2):273-80. PubMed ID: 15996702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sensitivity of the ELISA immunoenzyme test for detecting the antibody response of persons vaccinated with an inactivated influenza vaccine].
    Proietti E; Rapicetta M; Morace G; Arangio-Ruiz G; Macchia T; Mancini G
    Ann Ist Super Sanita; 1982; 18(3):521-4. PubMed ID: 7187838
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunization against influenza: comparison of various topical and parenteral regimens containing inactivated and/or live attenuated vaccines in healthy adults.
    Keitel WA; Cate TR; Nino D; Huggins LL; Six HR; Quarles JM; Couch RB
    J Infect Dis; 2001 Jan; 183(2):329-332. PubMed ID: 11110645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new intranasal influenza vaccine based on a novel polycationic lipid--ceramide carbamoyl-spermine (CCS) I. Immunogenicity and efficacy studies in mice.
    Joseph A; Itskovitz-Cooper N; Samira S; Flasterstein O; Eliyahu H; Simberg D; Goldwaser I; Barenholz Y; Kedar E
    Vaccine; 2006 May; 24(18):3990-4006. PubMed ID: 16516356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza vaccine 2005-2006.
    Med Lett Drugs Ther; 2005 Oct; 47(1220):85-7. PubMed ID: 16264371
    [No Abstract]   [Full Text] [Related]  

  • 19. Characteristic of humoral response of elderly to inactivated influenza vaccine.
    Siennicka J
    Arch Immunol Ther Exp (Warsz); 1996; 44(5-6):389-94. PubMed ID: 9017157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody response to influenza vaccine in coronary artery disease: a substudy of the FLUCAD study.
    Brydak LB; Romanowska M; Nowak I; Ciszewski A; Bilińska ZT
    Med Sci Monit; 2009 Jul; 15(7):PH85-91. PubMed ID: 19564837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.